Latest Articles

This article discusses what good dPCR data looks like, how substandard equipment can detract from data quality and what oncology researchers can do to get high-quality dPCR data that will provide accurate and efficient insight into tumor load.

Predatory conferences are the ramshackle distant cousin of your regular scientific event, a Fyre Festival of science (without the involvement of Ja Rule). It is getting harder to separate fake conferences from real ones. Given this deluge of dodgy science, we have created a guide to spotting and avoiding predatory conferences.

An automated and cost-effective workflow in immunopeptidomics, utilizing microfluidics technology, has been created that overcomes limitations in sample preparation and could be a powerful tool for tumor antigen discovery in sparse samples.

Scientists have identified a number of biomarkers associated with progression of Type 2 diabetes to predict insulin resistance development, which could help to manage the disease and improve patient outcomes.

This article explores complexities in proteomics and highlights some promising technological advances in this area.

In this article, we take a deep dive into the world of epigenetic aging clocks, finding out what they are, what they can tell us and how they might be applied in future.

This article sheds light on the issue of image integrity in academic publishing and gives advice on how to reduce the risk.

In this article, we dive into MRD and how it promises to both address an unmet need in the care of cancer patients and ultimately help patients live longer lives with less uncertainty.

In this opinion piece, Jan Wauters discusses why collaboration in science is so important and what the Windsor Framework could mean for research in Europe.

In this op-ed article, Michael Kinch explains his optimism around ChatGPT which, in his words, centers around the possibility that we as a society might start to question "claims" and "truths" that we encounter daily.